UnitedHealth Group Chairman and CEO Stephen Hemsley faces investor test as insurer reports earnings. Stock price halved, worst year in decade. Former CEO Witty resigned amid earnings drop, DOJ investigations. Investors look to Hemsley for plan out of crisis. Analysts await 2025 guidance, estimate full-year earnings $21.26 per share.

Focus on Medicare Advantage and Optum Health outlook. Optum Health profits decline due to V28 change in billing standards. Competitors adjust, UnitedHealth caught off guard. Analysts predict potential recovery but foresee worsening margins. Structural shift in margins due to V28 changes. Misexecution cited as reason for declining profits.

Legal and regulatory issues loom. DOJ probes UnitedHealth’s Medicare billing practices. Company cooperates with investigations. Investor fear overblown, likely outcome corporate integrity agreement. Pressure on insurers likely to increase. Congress scrutiny on health and drug costs. UnitedHealth hires auditors for review of business practices. Audit details to be disclosed end of third quarter.

Read more at CNBC: UnitedHealth UNH Q2 earnings preview